Eribulin Mesylate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.44 mg/mL
Reference Brands: HALAVEN (USA/EU)
Category:
Oncology Cancer Care
Eribulin mesylate is a microtubule dynamics inhibitor derived from the marine sponge Halichondria okadai. It is used for the treatment of patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. The drug works by inhibiting microtubule growth, leading to cancer cell cycle arrest and apoptosis. Halaven is administered intravenously under medical supervision and is recognized for extending survival in patients with advanced cancer.
Eribulin mesylate is available in Injection
and strengths such as 0.44 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Eribulin mesylate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Eribulin mesylate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing